SS

Sekhar Son Kandanur

Active Director Director DIN 03635296
DIN 03635296 First appointment Apr 2017 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2017
Shareholding value •••• Premium profile

About Sekhar Son Kandanur

Data last updated:

Sekhar Son Kandanur is a Director at Nucon Remedies Private Limited (since 2017). The company operates in Trading. Nucon Remedies Private Limited reported revenue of ₹58.1 Lakh (FY 2025).

DIN 03635296
Primary Designation Director
Industry Trading
First Appointment 20 Apr 2017
Oldest Company Age 15 yrs
Largest company Nucon Remedies Private Limited · ₹58.1 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nucon Remedies Private Limited U51101MH2011PTC223199
Director20 Apr 20172011₹58.1 Lakh (FY 2025)Active

Board colleagues of Sekhar Son Kandanur

NameDINCompanyDesignation
Chamarthy Raja Rao08297882Nucon Remedies Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nucon Remedies Private Limited
Premium access

Shareholding and investment profile for Sekhar Son Kandanur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sekhar Son Kandanur

Sekhar Son Kandanur currently holds 1 directorship: Nucon Remedies Private Limited (Director, since 20 Apr 2017, revenue ₹58.1 Lakh (FY 2025)).

Sekhar Son Kandanur was first appointed on 20 Apr 2017 as Director at Nucon Remedies Private Limited.

The current boards of Sekhar Son Kandanur's companies include Chamarthy Raja Rao (Nucon Remedies Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available